1696 related articles for article (PubMed ID: 9065402)
1. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.
Morin PJ; Sparks AB; Korinek V; Barker N; Clevers H; Vogelstein B; Kinzler KW
Science; 1997 Mar; 275(5307):1787-90. PubMed ID: 9065402
[TBL] [Abstract][Full Text] [Related]
2. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.
Korinek V; Barker N; Morin PJ; van Wichen D; de Weger R; Kinzler KW; Vogelstein B; Clevers H
Science; 1997 Mar; 275(5307):1784-7. PubMed ID: 9065401
[TBL] [Abstract][Full Text] [Related]
3. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.
Wakita K; Tetsu O; McCormick F
Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
5. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
6. CDX2 is mutated in a colorectal cancer with normal APC/beta-catenin signaling.
da Costa LT; He TC; Yu J; Sparks AB; Morin PJ; Polyak K; Laken S; Vogelstein B; Kinzler KW
Oncogene; 1999 Sep; 18(35):5010-4. PubMed ID: 10490837
[TBL] [Abstract][Full Text] [Related]
7. Identification of c-MYC as a target of the APC pathway.
He TC; Sparks AB; Rago C; Hermeking H; Zawel L; da Costa LT; Morin PJ; Vogelstein B; Kinzler KW
Science; 1998 Sep; 281(5382):1509-12. PubMed ID: 9727977
[TBL] [Abstract][Full Text] [Related]
8. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
9. Gut-enriched Krüppel-like factor regulates colonic cell growth through APC/beta-catenin pathway.
Stone CD; Chen ZY; Tseng CC
FEBS Lett; 2002 Oct; 530(1-3):147-52. PubMed ID: 12387883
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.
Sparks AB; Morin PJ; Vogelstein B; Kinzler KW
Cancer Res; 1998 Mar; 58(6):1130-4. PubMed ID: 9515795
[TBL] [Abstract][Full Text] [Related]
11. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW
Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138
[TBL] [Abstract][Full Text] [Related]
12. Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells.
Li Q; Dashwood RH
J Biol Chem; 2004 Oct; 279(44):45669-75. PubMed ID: 15331612
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
Tetsu O; McCormick F
Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
[TBL] [Abstract][Full Text] [Related]
14. Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis.
Koh TJ; Bulitta CJ; Fleming JV; Dockray GJ; Varro A; Wang TC
J Clin Invest; 2000 Aug; 106(4):533-9. PubMed ID: 10953028
[TBL] [Abstract][Full Text] [Related]
15. Beta-catenin as oncogene: the smoking gun.
Peifer M
Science; 1997 Mar; 275(5307):1752-3. PubMed ID: 9122680
[No Abstract] [Full Text] [Related]
16. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
[TBL] [Abstract][Full Text] [Related]
17. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
18. Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis.
Takahashi M; Fujita M; Furukawa Y; Hamamoto R; Shimokawa T; Miwa N; Ogawa M; Nakamura Y
Cancer Res; 2002 Oct; 62(20):5651-6. PubMed ID: 12384519
[TBL] [Abstract][Full Text] [Related]
19. APC 3 x 15 beta-catenin-binding domain potentiates beta-catenin association to TBP and upregulates TCF-4 transcriptional activity.
Roura S; Martínez D; Piedra J; Miravet S; García de Herreros A; Duñach M
Biochem Biophys Res Commun; 2003 Oct; 309(4):830-5. PubMed ID: 13679048
[TBL] [Abstract][Full Text] [Related]
20. A Drosophila homolog of the tumor suppressor gene adenomatous polyposis coli down-regulates beta-catenin but its zygotic expression is not essential for the regulation of Armadillo.
Hayashi S; Rubinfeld B; Souza B; Polakis P; Wieschaus E; Levine AJ
Proc Natl Acad Sci U S A; 1997 Jan; 94(1):242-7. PubMed ID: 8990193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]